Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Claritas Pharmaceuticals Inc
V.CLAS.H
Alternate Symbol(s):
CLAZF
Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID...
viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSXV:CLAS.H - Post Discussion
Claritas Pharmaceuticals Inc
> Sad but true.
New Post
View:
Discussion
List
(1)
•••
losingmyshirt
X
View Profile
View Bullboard History
Post by
losingmyshirt
on Jan 06, 2022 10:40am
Sad but true.
@malarkey
Fake News Clitaris Announces Strategy for the Nitric Oxide Formula R812 for Enhanced Orgasms and Increased Sexual Desire. Sanfrancisco, CA and Toronna, On Jan 2022 Clitaris -- Stockgroup CLYt are pleased to announce plans for another new strategy to develop R812, this time for the enhancement of sexual pleasure. “CLYT is poised to accelerate the development of R812 so that soon both men and women can expect bigger and better orgasms.” Said Director LMShirt Phase 1 Study will be complete after it commences sometime this year, stay tooned. Phase 2 which is a multiple will commence sometime after Phase 1 is completed Phase 2C will be a multiple phase focussing on making it easier for men to achieve and maintain erections while women will experience increased natural lubrication. Mister Shirt continued “ Nitric oxide can have sexual health benefits, improve cardiovascular health, promote energy level and moods, improve function and expedite recovery time.(wink, wink ) This is certainly what the world needs now” The Salesman Team were going to volunteer gratis but later decided to negotiate another Licence and have begun making room so that their sharecount is again less than 19%
(310)
•••
AngelaL
X
View Profile
View Bullboard History
Comment by
AngelaL
on Jan 06, 2022 11:53am
There is of course a vast literature on the nitric oxide pathway in sexual dysfunction. Viagra, for example, works by stabilizing cGMP which is induced by endogenous nitric oxide. For female sexual dysfunction there is also a growing scientific literature, since the erectile function of the clitoris and the lubrication of the vagina are mediated by endogenous nitric oxide stimulation of cGMP. I
...more
(1)
•••
Red~One
X
View Profile
View Bullboard History
Comment by
Red~One
on Jan 06, 2022 9:50pm
Whew, thanks for sharing
(27)
•••
PTBailey
X
View Profile
View Bullboard History
Comment by
PTBailey
on Jan 06, 2022 12:12pm
Serious question, if Claritas comes out with financial and start of phase one announcement will you still bash it?
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario